日韩综合一区二区三区,一本免费视频,成人黄色免费观看

中文站

Careers | Investors | Patients and HCPS | Contact us

Careers Investors Patients and HCPS Contact us

Search

# Popular search #

Diabetes Oncology Medical Devices

Company News

Company News Exhibitions Activities

All news 2025 2024 2023 2022 2021 2018

Gan & Lee Pharmaceuticals Announced First Participant Dosed in a Phase 3 Clinical Study (SUPER-1) of Once-weekly Basal Insulin GZR4 injection in Chinese Patients with Type 2 Diabetes Mellitus
Gan & Lee 2025-03-18
Gan & Lee Pharmaceuticals Announced First Participant Dosed in a Phase 3 Clinical Study (OPTIMUM-2) of Bofanglutide (GZR18) injection in Chinese Patients with Type 2 Diabetes Mellitus
Gan & Lee 2025-03-14
Insulin Glargine PDP Project Officially Approved at the National Level in Brazil
Gan & Lee 2025-03-13
Gan & Lee Pharmaceuticals Announced First Participant Dosed in the US Phase 2 Clinical Study of Bofanglutide (GZR18) Injection for Overweight or Obesity
Gan & Lee 2025-03-13
Gan & Lee Pharmaceuticals Announces Received Approval of Insulin Glargine Products in Malaysia
Gan & Lee 2025-02-14
Gan & Lee Pharmaceuticals Announced First Participant Dosed in a Phase 3 Clinical Study (GRADUAL-1) of Bofanglutide (GZR18) injection in Chinese Patients with Overweight or Obesity
Gan & Lee 2024-12-30

< 1 2 3 4 5 6 7 8 ... 14 15 >

Our websites

Gangan Technology

You are now leaving the Gan & Lee website.

The site you are about to visit is maintained by a third party who is responsible for its content.
This link is provided on the Gan & Lee website as a service to our visitors. Gan & Lee is not responsible for the privacy policy of any third-party websites. Gan & Lee encourages visitors to read the privacy policy of every website that you may visit.

Continue Back

Search

Subscribe